Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery
Not recruiting
Investigated Diseases:Investigated Drugs:
+5